Drug Target Analysis with Next-Generation
Metabolomics™ and Proteomics
With Panome Bio’s proprietary computational methods and cutting-edge proteomics capabilities, discover biomarkers of target and off-target drug effects. With multi-omic analysis, discover metabolic alterations and identify potential target molecules that play critical roles in disease pathways.
Small molecules often interact with more than one protein leading to unwanted off-target effects. Using dose-response
metabolomics and proteomics, samples can be evaluated for interaction with multiple proteins at various concentrations.